Imatinib: Major photocatalytic degradation pathways in aqueous media and the relative toxicity of its transformation products

Predicted concentrations of antineoplastic drugs in the aquatic environment: The case of Ría de Vigo (NW, Spain)

The European Medicines Agency (EMA) mandates Environmental Risk Assessments (ERAs) since 2006 to determine potential risks of new marketed medicines. Drugs with a Predicted Environmental Concentration (PEC) in inland surface waters exceeding 0.01 μg L-1 require further environmental risk assessment. PEC may be refined based on prevalence data and/or based on the treatment regimen. In this study, based on EMA regulations, refined PEC of 108 antineoplastic drugs in coastal waters were determined based on the consumption in a coastal health area during 2021, identifying six drugs with potential environmental risk in surface waters (hydroxyurea, capecitabine, abiraterone, ibrutinib, imatinib and 5-fluorouracil) and two in marine ecosystem (hydroxyurea and capecitabine). Comparison of these refined PECs with data from marketing laboratories revealed significant disparities, suggesting the need for regular updates, especially with changes in drug indications or financing. Notably, the identified drugs are not yet on the main reference lists of emerging contaminants.

Removal of chloramphenicol antibiotics in natural and engineered water systems: Review of reaction mechanisms and product toxicity

Chloramphenicol antibiotics are widely applied in human and veterinary medicine. They experience natural attenuation and/or chemical degradation during oxidative water treatment. However, the environmental risks posed by the transformation products of such organic contaminants remain largely unknown from the literature. As such, this review aims to summarize and analyze the elimination efficiency, reaction mechanisms, and resulting product risks of three typical chloramphenicol antibiotics (chloramphenicol, thiamphenicol, and florfenicol) from these transformation processes. The obtained results suggest that limited attenuation of these micropollutants is observed during hydrolysis, biodegradation, and photolysis. Comparatively, prominent abatement of these compounds is accomplished using advanced oxidation processes; however, efficient mineralization is still difficult given the formation of recalcitrant products. The in silico prediction on the multi-endpoint toxicity and biodegradability of different products is systematically performed. Most of the transformation products are estimated with acute and chronic aquatic toxicity, genotoxicity, and developmental toxicity. Furthermore, the overall reaction mechanisms of these contaminants induced by multiple oxidizing species are revealed. Overall, this review unveils the non-overlooked and serious secondary risks and biodegradability recalcitrance of the degradation products of chloramphenicol antibiotics using a combined experimental and theoretical method. Strategic improvements of current treatment technologies are strongly recommended for complete water decontamination.

Photocatalytic Activity of TiO2 for the Degradation of Anticancer Drugs

To prevent water pollution, photocatalysis is often used to remove small molecules such as drugs by generating reactive species. This study aimed to determine the photocatalytic activity of two anticancer drugs, imatinib and crizotinib, and to investigate various influences that may alter the kinetic degradation rate and ultimately the efficacy of the process. In order to obtain optimal parameters for the removal of drugs with immobilized TiO₂, the mutual influence of the initial concentration of the contaminant at environmentally relevant pH values was investigated using the response surface modeling approach. The faster kinetic rate of photocatalysis was obtained at pH 5 and at the smallest applied concentration of both drugs. The photocatalytic efficiency was mostly decreased by adding various inorganic salts and organic compounds to the drug mixture. Regarding the degradation mechanism of imatinib and crizotinib, hydroxyl radicals and singlet oxygen showed a major role in photochemical reactions. The formation of seven degradation products for imatinib and fifteen for crizotinib during the optimal photocatalytic process was monitored by high-resolution mass spectrometry (HPLC-QqTOF). Since the newly formed products may pose a hazard to the environment, their toxicity was studied using Vibrio fischeri, where the significant luminescence inhibition was assessed for the mixture of crizotinib degradants during the photocatalysis from 90 to 120 min.

Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties

In past decades, anticancer research has led to remarkable results despite many of the approved drugs still being characterized by high systemic toxicity mainly due to the lack of tumor selectivity and present pharmacokinetic drawbacks, including low water solubility, that negatively affect the drug circulation time and bioavailability. The stability studies, performed in mild conditions during their development or under stressing exposure to high temperature, hydrolytic medium or light source, have demonstrated the sensitivity of anticancer drugs to many parameters. For this reason, the formation of degradation products is assessed both in pharmaceutical formulations and in the environment as hospital waste. To date, numerous formulations have been developed for achieving tissue-specific drug targeting and reducing toxic side effects, as well as for improving drug stability. The development of prodrugs represents a promising strategy in targeted cancer therapy for improving the selectivity, efficacy and stability of active compounds. Recent studies show that the incorporation of anticancer drugs into vesicular systems, such as polymeric micelles or cyclodextrins, or the use of nanocarriers containing chemotherapeutics that conjugate to monoclonal antibodies can improve solubility, pharmacokinetics, cellular absorption and stability. In this study, we summarize the latest advances in knowledge regarding the development of effective highly stable anticancer drugs formulated as stable prodrugs or entrapped in nanosystems.

Sorption Potential of Different Forms of TiO2 for the Removal of Two Anticancer Drugs from Water

Anticancer drugs pose a potential risk to the environment due to their significant consumption and biological effect even at low concentrations. They can leach into soils and sediments, wastewater, and eventually into drinking water supplies. Many conventional technologies with more effective advanced oxidation processes such as photocatalysis are being extensively studied to find an economical and environmentally friendly solution for the removal of impurities from wastewater as the main source of these pharmaceuticals. Since it is impossible to treat water by photocatalysis if there is no sorption of a contaminant on the photocatalyst, this work investigated the amount of imatinib and crizotinib sorbed from an aqueous medium to different forms of photocatalyst. In addition, based on the sorption affinity studied, the applicability of sorption as a simpler and less costly process was tested in general as a potential route to remove imatinib and crizotinib from water. Their sorption possibility was investigated determining the maximum of sorption, influence of pH, ionic strength, temperature, and sorbent dosage in form of the suspension and immobilized on the fiberglass mesh with only TiO2 and in combination with TiO2/carbon nanotubes. The sorption isotherm data fitted well the linear, Freundlich, and Langmuir model for both pharmaceuticals. An increasing trend of sorption coefficients Kd was observed in the pH range of 5–9 with CRZ, showing higher sorption affinity to all TiO2 forms, which was supported by KF values higher than 116 (μg/g)(mL/μg)1/n. The results also show a positive correlation between Kd and temperature as well as sorbent dosage for both pharmaceuticals, while CRZ sorbed less at higher salt concentration. The kinetic data were best described with a pseudo-second-order model (R2 > 0.995).

Solar-driven photoelectrocatalytic degradation of anticancer drugs using TiO2 nanotubes decorated with SnS quantum dots

In recent years, the growing interest in applying photoelectrocatalysis (PEC) to decompose organic pollutants has resulted in the need to search for new photoelectrode materials with high activity under visible light radiation. The presented research showed an increased photoelectrocatalytic activity under sunlight of Ti/TiO₂ sensitized with SnS quantum dots, obtained by the successive ionic layer adsorption and reaction (SILAR) method. The presence of SnS caused the enhanced absorption of visible irradiation and the reduction of recombination of generated charges by a p-n heterojunction created with the TiO₂. The highest efficiency of photoelectrocatalytic degradation of anticancer drugs (ifosfamide, 5-fluorouracil, imatinib) was achieved for the SnS-Ti/TiO₂ photoelectrode with a SnS quantum dot size from 4 to 10 nm. In addition, a decrease of IF PEC degradation efficiency was observed with increasing pH and with the presence of Cl^-, NO₃^-, HCO₃^- and organic matter in the treated solution. Studies of the PEC mechanism have shown that drug degradation occurs mainly as a result of the direct and indirect action of photogenerated holes on the SnS-Ti/TiO₂ photoelectrode, and the identified degradation products allowed for the presentation of the degradation pathway of IF, 5-FU and IMB. Duckweed (Lemna minor) growth inhibition tests showed no toxicity of the drug solutions after treatment.

Ti/TiO2 nanotubes sensitized PbS quantum dots as photoelectrodes applied for decomposition of anticancer drugs under simulated solar energy

One of the challenges in research into photoelectrocatalytic (PEC) degradation of pollutants is finding the appropriate photoanode material, which has a significant impact on the process efficiency. Among all others, photoelectrodes based on an ordered TiO₂ nanotube arrays are a promising material due to well-developed surface area and efficient charge separation. To increase the PEC activity of this material, the SILAR method was used to decorate Ti/TiO₂ nanotubes by PbS quantum dots (QD). The ifosfamide (IF) degradation rate constants was twice as higher for PbS-Ti/TiO₂ (0.0148 min^-1) than for Ti/TiO₂ (0.0072 min^-1). Our research showed the highest efficiency of PEC degradation of drugs using IIIPbS-Ti/TiO₂ made with 3 SILAR cycles (PbS QD size mainly 2-4 nm). The 4 and 6 of SILAR cycles resulted in the aggregation of PbS nanoparticles on the Ti/TiO₂ surface and decreased IF PEC degradation rate to 0.0043 and 0.0033 min^-1, respectively. Research on PEC mechanism has shown that the drugs are degraded mainly by the activity of photogenerated holes and hydroxyl radicals. In addition, the identified drug intermediates made possible to propose a degradation pathways of anticancer drugs and the ecotoxicity test show no inhibition of Lemna minor growth of treated solutions.

Aquatic ecotoxicology of anticancer drugs: A systematic review

Anticancer drugs in the aquatic environment have drawn a lot of attention in the last decade. Since wastewater treatment plants are inefficient at fully eliminating trace concentrations of anticancer drugs, these compounds are continuously discharged into the aquatic environment. Subsequently, non-target organisms such as the aquatic biota are directly exposed to a variety of anticancer drugs. To understand the potential impact on the aquatic organisms, a systematic review was conducted in compliance with the PRISMA guidelines. The results acquired from the 152 included studies were analysed and sorted into four categories: the impact of each included anticancer drug, the effect of metabolites, the effect of a mixture of drugs, and risk assessment. Findings showed that risk to the aquatic biota was unlikely to occur as the concentrations needed to induce effects were much higher than those detected in the environment. However, these data were based on acute toxicity and included only basic toxicity endpoints. The concentrations that produced significant effects were much lower when tested in the long-term or in multi-generational studies. Heterogeneity in results was also observed; this depended on the organism tested, the assessment adopted, and the endpoints selected. In this systematic review, an overall view of the research studies was generated by which all the variability factors to be considered were reported and recommendations to guide future studies were proposed.

A novel workflow utilizing open-source software tools in the environmental fate studies: The example of imatinib biotransformation

The aim of this study is to utilize novel and powerful workflows with publicly available tools to efficiently process data and facilitate rapid acquisition of knowledge on environmental fate studies. Taking imatinib (IMA) as an example, we developed an efficient workflow to describe IMA biodegradation with activated sludge (AS) from wastewater treatment plants (WWTP). IMA is a cytostatic pharmaceutical; a selective tyrosine kinase inhibitor used to treat chronic myeloid leukemia. Its reported ecotoxic, endocrine and genotoxic effects imply high risk for aquatic wildlife and human health, however its fate in the environment is not yet well known. The study was conducted in a batch biotransformation setup, at two AS concentration levels and in presence and absence of carbon source. Degradation profiles and formation of IMA transformation products (TPs) were investigated using UHPLC-QqOrbitrap-MS/MS which showed that IMA is readily biodegradable. TPs were determined using multivariate statistical analysis. Eight TPs were determined and tentatively identified, six of them for first time. Hydrolysis of amide bond, oxidation, demethylation, deamination, acetylation and succinylation are proposed as major biodegradation pathways. TP235, the product of amide bond hydrolysis, was detected and quantified in actual wastewaters, at levels around 1 ng/L. This calls for more studies on the environmental fate of IMA in order to properly asses the environmental risk and hazard associated to IMA and its TPs.

Treatment-driven removal efficiency, product formation, and toxicity evolution of antineoplastic agents: Current status and implications for water safety assessment

Antineoplastic compounds, designed for chemotherapeutic anticancer therapy, have become emerging contaminants of global concern over the past decade due to their ubiquitous occurrence, environmental persistence, and multiple adverse effects on aquatic ecosystems. Increasing efforts have been devoted to developing efficient strategies for remediating water containing these micropollutants. In this study, the physicochemical properties, natural attenuation, and chemical reactivity with aqueous oxidizing species of five antineoplastic drugs with the highest environmental prevalence (i.e., tamoxifen, cyclophosphamide, ifosfamide, 5-fluorouracil, and methotrexate) were summarized. The removal performance, transformation products (TPs) of varying structures, overall reaction pathways, and toxicity evolution during different treatments were evaluated and discussed. Additionally, the biodegradability and multi-endpoint toxicity of each TP were predicted using in silico QSAR software. Depending on their distinct inherent structures, the reactivity of the antineoplastics with oxidizing species varied, with hydroxyl radicals exhibiting unparalleled merits in rapid oxidation. Complete elimination of these contaminants was observed during oxidative treatments, but with inadequate mineralization. Notably, the increase in toxicity within multiple processes was determined based on both experimental bioassays and theoretical predictions. This may be attributed to the adverse effects induced by the large number of identified and unknown TPs individually and in combination. Together with the environmental persistence and low biodegradability of most TPs, these results necessitate the application of efficient post-treatments in conjunction with a more thorough water safety evaluation (e.g., using high-throughput screening) of the mixtures of treated water and wastewater.

UV and visible-assisted photocatalytic degradation of pharmaceutical pollutants in the presence of rational designed biogenic Fe3O4-Au nanocomposite

In this study, we designed Fe3O4 nanoparticles and heterogeneous Fe3O4-Au nanocomposites with a mean size of 21 and 27 nm that synthesized by Foeniculum vulgare seed extract to photodegrade organic micropollutants under UV and visible light irradiation. The physiochemical characteristics of biogenic nanoparticles/nanocomposite are described by XRD, FTIR, UV-Vis, SEM, EDX, and X-ray elemental mapping. In the presence of nanoparticles and nanocomposites under UV irradiation, the total degradation of contaminants is about 85-90% after 2100 s, while under visible light irradiation, degradation efficiencies are about 70-85% after 4800-s irradiation. Total organic carbon analysis results confirmed photodegradation efficacies. Also, the scavenger's experiments show that hydroxyl radical is the most important specie in the degradation of pollutant model. It can be concluded clearly that Fe3O4 green nanoparticles and Fe3O4-Au green nanocomposite are very simple and effective photocatalyst for degradation of organic pollutants in very short time under illumination.

Ruxolitinib photodegradation mechanisms by theoretical and experimental chemistry

Ruxolitinib is a Janus Kinase inhibitor currently approved for the treatment of myelofibrosis. It is also a promising drug for the treatment of skin and infectious diseases. In terms of pharmaceutical stability, although ruxolitinib has been established as being sensitive to light, no data on photodegradation processes are available to date, while these may be useful for quality risk management and any potential development of other pharmaceutical forms for other routes of administration. One way to partially fill this gap was to carry out a study that combines a consistent determination of the most sensitive sites of the molecule to photolysis through theoretical calculations based on functional density, with the identification of the main photodegradation products obtained after forced degradation. This integrated approach has shown converging results describing the mechanisms based on photo-oxidation that can lead to the opening of the pyrrole ring. Having access to the structure of the degradation products and intermediates then made it possible to carry out an in silico evaluation of their potential mutagenicity and it appears that some of them feature alert structures.

Synthesis, extracorporeal nephrotoxicity, and 3D-QSAR of andrographolide derivatives

Andrographolide is a traditional Chinese medicine monomer with many pharmacological activities, but has potential nephrotoxicity. Here, we aim to investigate the relationship between modification of andrographolide structure and its nephrotoxicity. Twenty-three andrographolide derivatives were synthesized, and their structures were confirmed by ¹ H-NMR and HRMS. Nephrotoxicity of these compounds against human renal tubular epithelial (HK-2) cells was evaluated using the MTT assay. The results indicated that most of them had significantly reduced nephrotoxicity, especially compounds III, V, and IX_c , with IC₅₀ values of 1,985, 1,300, and 806.9 μmol/L, respectively, which were obviously superior to andrographolide (IC₅₀ 30.60 μmol/L). However, compounds I_a -I_f (IC₅₀ values < 30 μmol/L), the 14-OH derivatives of andrographolide, showed higher nephrotoxicity than that of andrographolide. Three-dimensional quantitative structure-activity relationship (3D-QSAR) models of COMFA and COMSIA were established (COMFA: q²  = 0.639, r²  = 0.951; COMSIA: q²  = 0.569, r²  = 0.857). This model allowed proposing five new compounds with lower theoretical nephrotoxicity, which would be worthwhile to synthesize and evaluate. We believe that predicted models will help us to understand the structural modification requirements of andrographolide to reduce the nephrotoxicity, and further investigations will be needed to determine the mechanism involved in the effect of less nephrotoxic compounds.

Environmental risk assessment of widely used anticancer drugs (5-fluorouracil, cisplatin, etoposide, imatinib mesylate)

Anticancer drugs are among the most toxic chemicals, which are commercially produced; therefore, their release in aquatic ecosystems raised concerns in regard to potential adverse effects. This article describes the results of risk assessments concerning their environmental safety, which are based on data generated in the frame of a coordinated EU project ("Cytothreat"). Eight research institutions participated in the project and four widely used anticancer drugs with different mechanisms of therapeutic action (5-fluorouracil 5FU, cisplatin CDDP, imatinib mesylate IM and etoposide ET) were tested in a variety of indicator organisms (cyanobacteria, algae, higher plants, rotifers, crustacea, fish and also in human and fish derived cell lines) in acute/subacute/chronic toxicity assays. Furthermore, genotoxic effects in micronucleus assays, single cell gel electrophoresis experiments and γH2AX tests were studied in plants, crustacea, fish and in various cell lines. We used the results to calculate the predicted no effect concentrations (PNEC) and risk quotients (RQ) by comparing PNEC with predicted environmental concentrations (PEC values) and measured concentrations (MEC) in wastewaters. The most sensitive species in experiments concerning acute toxic and long term effects were in general crustacea (daphnids) after chronic treatment the most pronounced effects were detected with IM followed by CDDP and 5FU. Comparisons between PNEC and PEC values indicate that it is unlikely that the release of these drugs in the aquatic environments leads to adverse effects (RQ values < 1). However, when the assessments were performed with MEC found in highly contaminated municipal wastewaters and hospital effluents, RQ values were obtained which are indicative for moderate adverse effects of IM. Calculations with data from genotoxicity experiments and PEC values are indicative for increased RQ values for all compounds except ET. The most sensitive species were fish (Danio rerio) which were highly responsive towards 5FU and daphnids which were sensitive towards CDDP and IM. When environmental data (from waste waters) were used for the calculations, high RQ values (>100) were obtained for CDDP and IM. These overall conclusions were not substantially altered when the effects of other frequently used cytostatic drugs and combined effects of mixtures of anticancer drugs were taken into consideration. The results of these assessments underline the importance of efficient removal of these chemicals by improved sewage treatment strategies and the need for further investigations of adverse the long term effects of cytostatics in aquatic biota as a consequence of damage of the genetic material in highly sensitive species.